Industrial Alliance Investment Management Inc. Vertex Pharmaceuticals Inc Transaction History

Industrial Alliance Investment Management Inc.

$196 Million
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $26,499 - $28,995	65 Added 3.8%	1,774 $742,000
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $122,451 - $146,612	-357 Reduced 17.28%	1,709 $695,000
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $461,953 - $495,120	1,366 Added 195.14%	2,066 $718,000
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $12.7 Million - $14.3 Million	-40,532 Reduced 98.3%	700 $246,000
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $2.54 Million - $2.89 Million	-8,957 Reduced 17.85%	41,232 $13 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $3.59 Million - $4.04 Million	-12,559 Reduced 20.01%	50,189 $14.5 Million
Q3 2022 Nov 18, 2022	BUY	$273.83 - $305.53 $3.67 Million - $4.1 Million	13,413 Added 27.19%	62,748 $18.2 Million
Q2 2022 Aug 10, 2022	BUY	$234.96 - $292.55 $1.49 Million - $1.85 Million	6,333 Added 14.73%	49,335 $13.9 Million
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $1.03 Million - $1.21 Million	-4,630 Reduced 9.72%	43,002 $11.2 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $6.58 Million - $8.31 Million	37,172 Added 355.37%	47,632 $10.5 Million
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $1.85 Million - $2.34 Million	10,460 New	10,460 $47.6 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.5 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.8 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.9 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.49 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.18 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Industrial Alliance Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Industrial Alliance Investment Management Inc. with notifications on news.

Account